STEM vs UTHR · rev $144.6M vs P/E 20, rev $2.88B
Stem Inc (STEM) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Stem Inc (STEM) is a utilities - renewable company listed on US.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported STEM revenue for 2024-12-31 was $144.6M. Net income was -$854.0M. Revenue was down 68.7% from 2023-12-31 to 2024-12-31. STEM currently screens at market cap $82.1M.
Latest reported UTHR revenue for 2024-12-31 was $2.88B. Net income was $1.20B. Revenue was up 23.6% from 2023-12-31 to 2024-12-31. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
STEM currently screens at market cap $82.1M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the STEM and UTHR stock pages for the full models.
Not investment advice.